Search research articles
Contact Us
Filters
Showing results (371-380 of 529) with videos related to
Page
of 53
Sort By:
Journal of Clinical and Experimental Neuropsychology
|
July 9, 2008
Fitness to drive in multiple sclerosis: awareness of deficit moderates risk
Kelly A Ryan, Lisa J Rapport, Kaja Telmet Harper, et al.
Bioresource Technology
|
August 27, 2024
Unveiling key impact parameters and mechanistic insights towards activated biochar performance for carbon dioxide reduction
Wen Qian Chen, Jit Cyrus Loong Foo, Andrei Veksha, et al.
Cancers
|
December 30, 2025
Would Biopsy Change the Management of Kidney Cancer in the Coming Decade? The Role of Biopsy in Small Renal Masses: A Narrative Review
Łukasz Dariusz Lisak, Paweł Hełka, Aleksandra Kaźmierczak, et al.
Neurology
|
September 1, 1981
Polyclonal B-cell activity in myasthenia gravis
A I Levinson, A Dziarski, R P Lisak, et al.
The Analyst
|
September 7, 2022
Ion-selective membrane modified microfluidic paper-based solution sampling substrates for potentiometric heavy metal detection
Rochelle Silva, Ke Zhao, Ruiyu Ding, et al.
The American Journal of Pathology
|
November 1, 1984
The immunohistology of the thymus in myasthenia gravis
M J Kornstein, J J Brooks, A O Anderson, et al.
The Journal of Chemical Physics
|
December 11, 2013
Low-pressure line-shape study in molecular oxygen with absolute frequency reference
J Domysławska, S Wójtewicz, A Cygan, et al.
Neuroscience Letters
|
April 1, 1980
Antisera to bovine oligodendroglia raised in guinea pigs bind to surface of rat oligodendroglia and Schwann cells
R P Lisak, R M Pruss, P G Kennedy, et al.
European Journal of Neurology
|
April 4, 2001
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis
O A Khan, A C Tselis, J A Kamholz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 25, 2008
Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence
A Boster, C Caon, J Perumal, et al.
Page
of 53
Search research articles
Search
Showing results (371-380 of 529) with videos related to
Sort By:
Page
of 53
Journal of Clinical and Experimental Neuropsychology
|
July 9, 2008
Fitness to drive in multiple sclerosis: awareness of deficit moderates risk
Kelly A Ryan, Lisa J Rapport, Kaja Telmet Harper, et al.
Bioresource Technology
|
August 27, 2024
Unveiling key impact parameters and mechanistic insights towards activated biochar performance for carbon dioxide reduction
Wen Qian Chen, Jit Cyrus Loong Foo, Andrei Veksha, et al.
Cancers
|
December 30, 2025
Would Biopsy Change the Management of Kidney Cancer in the Coming Decade? The Role of Biopsy in Small Renal Masses: A Narrative Review
Łukasz Dariusz Lisak, Paweł Hełka, Aleksandra Kaźmierczak, et al.
Neurology
|
September 1, 1981
Polyclonal B-cell activity in myasthenia gravis
A I Levinson, A Dziarski, R P Lisak, et al.
The Analyst
|
September 7, 2022
Ion-selective membrane modified microfluidic paper-based solution sampling substrates for potentiometric heavy metal detection
Rochelle Silva, Ke Zhao, Ruiyu Ding, et al.
The American Journal of Pathology
|
November 1, 1984
The immunohistology of the thymus in myasthenia gravis
M J Kornstein, J J Brooks, A O Anderson, et al.
The Journal of Chemical Physics
|
December 11, 2013
Low-pressure line-shape study in molecular oxygen with absolute frequency reference
J Domysławska, S Wójtewicz, A Cygan, et al.
Neuroscience Letters
|
April 1, 1980
Antisera to bovine oligodendroglia raised in guinea pigs bind to surface of rat oligodendroglia and Schwann cells
R P Lisak, R M Pruss, P G Kennedy, et al.
European Journal of Neurology
|
April 4, 2001
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis
O A Khan, A C Tselis, J A Kamholz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 25, 2008
Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence
A Boster, C Caon, J Perumal, et al.
Page
of 53